Ministry of Health, Pharmacy Division STOCK STATUS REPORT AS AT 1 JULY 2013

Transcription

1 istry of Health, Pharmacy Division STOCK STATUS REPORT AS AT 1 JULY 2013 Introduction The purpose of this report is to inform the istry of Health and all stakeholders of the stock levels in the country in order for appropriate logistics decisions to be made and implemented. This report highlights challenges, bottlenecks and recommends potential solutions to mitigate stock outs and expiries of ARVs & HIV test kits, ACTs, AntiTB medicines, Reproductive Health items, selected Laboratory commodities,vaccines and selected medicines for Opportunistic Infections. It can be used to: Act as an early warning indicator for potential stock outs and possible expiries of EMHS Identify challenges and recommendations to avert supply interruptions Encourage preparation and sharing of joint supply plans with stakeholders Identify strategies for regularly reviewing supply plans for all the commodities Encourage donors to honor their commitments in terms of quantities of products expected, timeliness of deliveries and flexibility Summary of Key Issues 1. HIV/AIDS Commodities TDFbased formulations are well stocked nationally; TDF/3TC/EFV will be opened up for ART use, in addition to PMTCT, starting in July NMS is low on adult AZT based formulations and EFV 600. Orders have been placed to fill the public sector ARV gap up to December 2013 and deliveries are expected to arrive in the country between August and October Deliveries from Quality Chemicals Industry Limited (QCIL) are also expected at the end of July 2013 and SCMS shipments expected to arrive at JMS in August 2013 been redirected to NMS. UNITAID will place orders in July for the paediatric drugs that are low in stock at NMS. An order for NVP syrup for emtct has been placed to replenish stock at NMS. In the interim, some stock of NVP syrup will be transfered from JMS to NMS. At MAUL, EFV 100 is available to be used in place of EFV 200 which is stocked out but with pipeline expected by the end of July Increased uptake of the NVP 50 tablets versus the syrup for ART is recommended and interwarehouse transfer of the NVP 50 tablets shall be initiated to avoid expiries. 2. Medicines for Opportunistic Infections MAUL has adequate stock of fluconazole tablets. Pfizer has approved a procurement request from Uganda to meet the needs for all the warehouses for 12 months, with delivery dates to be confirmed and expedited. Cotrimoxazole 960 tablets is low on stock at NMS and MAUL, 3. Antimalarials Central level stock for ACTs at NMS appear low, however preliminary Medicines Management Supervision reports indicate ~70% facilities are adequately stocked (2+ months). Additional orders have been placed through GF for central level and products are expected by OctDec Deliveries from Quality Chemicals are also expected in July and October NMS continues to call off quinine injection, artesunate injection and SP from the framework contract. 4. Laboratory There are currently low stock levels at NMS for key laboratory commodities. Procurement for Determine test kits from PEPFAR and Global Fund underway. PEPFAR procurement of CD4 commodities for the public sector underway. Further DFID funding towards lab commodities has been confirmed and allocated towards HIV test kits, Hematology, clinical Chemistry and General reagents. For JMS, deliveries from PEPFAR are to arrive in AugSept 2013 to provide for remainder of year. 5. Anti TB Medicines Although central level stock of RH and RHE is low, most health facilities are well stocked. Consignments of RH paed and RHE that arrived recently from GF are to be verified. Global Fund orders have been approved and procurement is underway. Capreomycin,Cycloserine, and Paser at risk of expiry. Quantities at risk of expiry will be loaned other countries. 6. Reproductive Health Key commodities are well stocked. for products that are stocked out to be monitored. 7. Vaccines Although the polio trivalent stock is inadequate, the bivalent vaccine is sufficently stocked to cover the current need no risk of stock outs. No expiry risks to date. 8. Tracer Medicines Procurement of ORS to be expedited.

2 istry of Health, Pharmacy Division STOCK STATUS REPORT AS OF 1 JULY HIV/AIDS Commodities a) ARVs Adult Stock Status (July 1'13) & Total confirmed deliveries in next three months (July to Sept'13) National NMS AZT/3TC 300/150/ /150 TDF/3TC TDF/3TC/EFV EFV 600 NVP 200 ATV/r 300/100 LPV/r 200/50 300/ /300/ /150/200 AZT/3TC 300/150 TDF/3TC 300/300 TDF/3TC/EFV 300/300/600 EFV 600 NVP 200 ATV/r 300/100 LPV/r 200/50 JMS MAUL AZT/3TC TDF/3TC TDF/3TC/EFV EFV 600 NVP 200 ATV/r 300/100 LPV/r 200/50 300/150/ / / /300/ AZT/3TC TDF/3TC TDF/3TC/EFV EFV 600 NVP 200 ATV/r 300/100 LPV/r 200/50 300/150/ / / /300/600 Please see over 6 Months to view months of stock including deliveries and consumption over time. b) ARVs Paediatric National AZT/3TC 60/30 ABC/3TC 60/30 EFV 200 NVP 50 LPV/r 100/25 60/30/50 NMS AZT/3TC 60/30 ABC/3TC 60/30 EFV 200 NVP 50 LPV/r 100/25 60/30/50 JMS MAUL AZT/3TC 60/30 ABC/3TC 60/30 EFV 200 NVP 50 LPV/r 100/25 60/30/ AZT/3TC 60/30 ABC/3TC 60/30 EFV 200 NVP 50 LPV/r 100/25 60/30/50 Please see over 6 Months to view months of stock including deliveries and consumption over time.

3 ARVs Adult and Paediatric Formulation NMS JMS MAUL Comment Stock out risk Below 2 Adult 300/150/200 AZT/3TC 300/150 NMS All GF consignment delivered. QC and PEPFAR deliveries for NMS expected in July and August respectively. NMS All GF consignment delivered. QC and PEPFAR deliveries for NMS expected in July and August respectively. Adequate stock imum stock Below 3 Within 36 months of stock TDF/3TC 300/300 TDF/3TC/EFV 300/300/600 EFV 600 JMS pipeline expected in August from PEPFAR NMS Very well stocked. Supply to be opened up to other patients other than PMTCT. NMS All GF consignment delivered. QC and PEPFAR deliveries for NMS expected in July and August respectively. NVP 200 ATV/r 300/100 LPV/r 200/50 Paediatric 60/30/50 AZT/3TC 60/30 ABC/3TC 60/30 EFV 200 NVP 50 NVP 100 ml / NVP 240 ml NMS UNITAID will place orders in July 2013, expected delivery in SeptOct NMS UNITAID will place orders in July 2013, expected delivery in SeptOct Inter warehouse transfer to be initiated. NMS UNITAID will place orders in July 2013, expected delivery in SeptOct MAULEFV 100 will be used and EFV 200 pipeline expected end of July Uptake of NVP 50 to be encouraged at facility level. Order placed by PEPFAR to replenish stock at NMS. All GF shipments for 2013 delivered. LPV/r 100/25 LPV/r 80/20 /ml NMS UNITAID will place orders in July 2013, expected delivery in SeptOct Interwarehouse transfer to be initiated. TDFbased formulations are well stocked nationally; TDF/3TC/EFV will be opened up for ART use, in addition to PMTCT, starting in July NMS is low on adult AZT based formulations and EFV 600. Orders have been placed to fill the public sector ARV gap up to December 2013 and deliveries are expected to arrive in the country between August and October Deliveries from Quality Chemicals Industry Limited (QCIL) are also expected at the end of July 2013 and SCMS shipments expected to arrive at JMS in August 2013 been redirected to NMS. UNITAID will place orders in July for the paediatric drugs that are low in stock at NMS. An order for NVP syrup for emtct has been placed to replenish stock at NMS. In the interim, some stock of NVP syrup will be transfered from JMS to NMS. At MAUL, EFV 100 is available to be used in place of EFV 200 which is stocked out but with pipeline expected by the end of July Further procurement will be initiated to fill any gaps between September to December Increased uptake of the NVP 50 tablets versus the syrup for ART is recommended and interwarehouse transfer of the NVP 50 tablets shall be initiated to avoid expiries. 2. Medicines for Opportunistic Infections Stock Status (July 1'13) & Total confirmed deliveries in next three months (Jul to Sept'13) National NMS Fluconazole 200 Fluconazole 2/ml I.V. Fluconazole 50/5ml oral Infusion 100ml suspension Cotrimoxazole 960 Tab** 0.0 Fluconazole 200 Fluconazole 2/ml I.V. Fluconazole 50/5ml oral Infusion 100ml suspension Cotrimoxazole 960 Tab** JMS MAUL Fluconazole Fluconazole 2/ml I.V. Fluconazole 50/5ml oral 200 Infusion 100ml suspension Cotrimoxazole 960 Tab** Fluconazole 200 Fluconazole 2/ml I.V. Fluconazole 50/5ml oral Cotrimoxazole 960 Tab** Infusion 100ml suspension Stock out risk Below 2 Formulation NMS JMS MAUL Comments Adequate stock imum stock (3 months) Below 3 MOS Within 36 Months Please see over 6 Monthsto view months of stock including deliveries and consumption over time. Fluconazole 200(Diflucan) Fluconazole 2/ml I.V. Infusion 100ml (Diflucan) Fluconazole 50/5ml oral suspension (Diflucan) Cotrimoxazole 960 Tab Orders will be placed in July 2013 Low utilisation. Orders wil be placed in July 2013 Low utilisation. Orders wil be placed in July 2013 GF deliveries will be made in July 2013

4 MAUL has adequate stock of fluconazole tablets. Pfizer has approved a procurement request from Uganda to meet the needs for all the warehouses for 12 months, with delivery dates to be confirmed and expedited. Cotrimoxazole 960 tablets is low on stock at NMS and MAUL, but deliveries are expected in July 2013 for NMS and August 2013 for MAUL. JMS has adequate stock.

5 3. Antimalarials Stock Status (July 1'13) & Total confirmed deliveries in next three months (JulSept'13) National NMS JMS Months stock of ACT 20/120 tab, 24 pack ACT 20/120 tab, 18 pack ACT 20/120 tab, 12 pack ACT 20/120 tab, 6 pack Please see over 6 Months to view months of stock including deliveries and consumption over time. Stock out risk Below 2 Formulation NMS JMS Comments ACT 20/120 tab, 24 pack imum stock Below 3 ACT 20/120 tab, 18 pack ACT 20/120 tab, 12 pack NMSAdditional orders placed through GF. Products to be expected by Oct Dec Adequate stock Within 36 ACT 20/120 tab, 6 pack Artesunate Injection 60/ml Quinine HCl injection, 600/2ml SulphadoxinePyrimethamine 500/25 tab* NMS and PMI orders have been placed. NMS pipeline expected in July 2013 NMS to call off product from the framework contract NMS to call off product from the framework contract Central level stock for ACTs at NMS appear low, however preliminary Medicines Management Supervision reports indicate ~70% facilities are adequately stocked (2+ months). Additional orders have been placed through GF for central level and products are expected by OctDec Deliveries from Quality Chemicals are also expected in July and October NMS continues to call off quinine injection, artesunate injection and SP from the framework contract. JMS is well stocked with ACTs.

6 4. Laboratory Stock Status (July 1'13) & Total confirmed deliveries in next three months (Jul to Sept'13) National NMS JMS MAUL Months stock of Determine HIV 1/2 Rapid Test Kit 6.6 PartecCD4 Easy Count Kit Alere Pima CD4 100X Catridge Kit 2.4 FACS Count CD4/CD3/CD8 50 TESTS Please see over 6 Months to view months of stock including deliveries and consumption over time. Stock out risk Below 2 MOS imum stock Below 3 MOS Formulation NMS JMS MAUL Malaria Rapid diagnostic kits Determine HIV 1/2 Rapid Test Kit PartecCD4 Easy Count Kit Alere Pima CD4 100X Catridge Kit FACS Count CD4/CD3/CD8 50 TESTS Comments NMSProcurement from PEPFAR, GFPR1 and PR2 ongoing. NMS DFID funding to be used to procure. NMS Procurement from PEPFAR underway. UNITAID procurement pending MOU signing. NMS Procurement from PEPFAR underway. Adequate stock Within HUMACOUNT DILUENT NIHON KOHDEN MEK DILUENT Coulter Diluent Sysmex Cell Pack HUMAN GOT (ASAT) LIQUICOLOR COBAS c 311 ALT There are currently low stock levels at NMS for key laboratory commodities. Procurement for Determine test kits from PEPFAR and Global Fund underway. PEPFAR procurement of CD4 commodities for the public sector underway. Further DFID funding towards lab commodities has been confirmed and allocated towards HIV test kits, Hematology, clinical Chemistry and General reagents. For JMS, deliveries from PEPFAR are to arrive in AugSept 2013 to provide for remainder of year.

7 5. Anti TB Medicines Stock Status (July 1'13) & Total confirmed deliveries in next three months (Jul to Sept'13) National/NMS RHZE tablet EH twoweek blister RH (Adult) tablet (Pediatric) tablet (150/75/275 (Pediatric) vial RH RHE ) RHZ tablet Streptomycin 1g 75/150/275/400/ strip 400/150 60/30/75 Please see over 6 Monthsto view months of stock including deliveries and consumption over time. Stock out risk Adequate stock Below 2 MOS imum stock Below 3 MOS Within Formulation NMS Comments RHZE tablet 75/150/275/400/ EH twoweek blister strip RH (Adult) tablet Incountry stock to be confirmed. RH (Pediatric) tablet RHE (150/75/275 ) Incountry stock to be confirmed. RHZ (Pediatric) tablet 60/30/75 Streptomycin vial 1g Capreomycin 1G Vials To be donated. Cycloserine 250 Tablets To be donated. Ethionamide 250 Tablets Kanamycin 1G Vials Levofloxacin 250 Tablets Moxifloxacin 400 Tablets Paser 4 GM Sachets To be donated. Although central level stock of RH and RHE is low, most health facilities are well stocked. Consignments of RH paed and RHE that arrived recently from GF are to be verified. Global Fund pipeline approved and procurement underway. Capreomycin,Cycloserine, and Paser at risk of expiry. Quantities at risk of expiry will be loaned other countries.

8 6. Reproductive Health Stock Status (July 1'13) & Total confirmed deliveries in next three months (Jul to Sept'13) Public/NMS Private Please see over 6 Months to view months of stock including deliveries and consumption over time. Stock out risk Adequate stock Below 2 MOS imum stock Below 3 MOS Within Formulation DepoProvera (Medroxyprogesterone Acetate 150/ml INJ) Implants (Implanon& Jadelle) IUD Copper Containing Device TCU380A Combined Oral Contraceptives (Microgynon) Progestinonly oral contraceptives Male Condom Manual Vacuum Aspiration (MVA) Double Valve Mama Kit Female Condom Levonorgestrel 750 mcg Tab (Emerg. Contraceptive) Misoprostol 200mcg Tabs Gynaecological gloves NMS Private Comments Key commodities are well stocked. for products that are stocked out to be monitored.

9 7. Vaccines Stock Status (July 1'13) & Total confirmed deliveries in next three months (Jul to Sept'13) National/NMS Measles Vaccine 10 Bacillus Calmette Human papilloma Hepatitis B, 10 DPTHEPB+HIB) 1 Tetanus toxoid Polio oral trivalent Polio Oral Bivalent dose vial Guerin (BCG),20 Virus (HPV),1 dose dose vial dose vial vaccine (TT) 20 (TopV) 20 dose, vial(bopv) 20 dose vial dose vial vial Diphtheria, dose vial Pertusis Please see over 6 Months to view months of stock including deliveries and consumption over time. Stock out risk Below 2 MOS Formulation NMS Adequate stock Within imum stock Below 3 MOS Measles Vaccine 10 dose vial Bacillus CalmetteGuerin (BCG),20 dose vial Human papilloma Virus (HPV),1 dose vial Hepatitis B, 10 dose vial DPTHEPB+HIB) 1 dose vial Diphtheria, Pertusis Tetanus toxoid vaccine (TT) 20 dose vial Polio oral trivalent (TopV) 20 dose, vial Polio Oral Bivalent (BOPV) 20 dose vial Comments Although the polio trivalent stock is inadequate, the bivalent vaccine is sufficently stocked to cover the current need no risk of stock outs. No expiry risks to date. National 8. Tracer Medicines Stock Status (July 1'13) & Total confirmed deliveries in next three months (Jul to Sept'13) k DepoProvera ArtemetherLumefantrine Cotrimoxazole 960 Oral Rehydration Salts for 1 Measles Vaccine (Medroxyprogesterone 20/120 tab (Green), 24 Litre Acetate 150/ml INJ)* pack* Please see over 6 Months to view months of stock including deliveries and consumption over time. Formulation Nat'l Stock out risk Below 2 MOS imum stock Below 3 MOS DepoProvera ArtemetherLumefantrine Cotrimoxazole 480 Oral Rehydration Salts for 1 Litre Adequate stock Within Measles Vaccine Comments Procurement of ORS to be expedited.

10 istry of Health, Pharmacy Division STOCK STATUS REPORT AS AT 1 JULY 2013 National and Warehouse Six Month Analysis of Consumption Trends and Deliveries Introduction Below are the six month consumption trends together with deliveries for ARVs & HIV test kits, ACTs, AntiTB medicines, Reproductive Health items, selected Laboratory commodities and selected medicines for opportunistic infections to assist in mitigating stock outs and reducing expiries. Stock levels are forecasted using estimated average monthly consumption and include expected confirmed pipeline (Drugs yet to be delivered in the next six months) HIV/AIDS Commodities ARVs Adult and Paediatric National and by Warehouse on Hand by Formulation including deliveries (with a confirmed delivery date) for the next six months. Note: on hand for each month reflect remaining months of stock (MOS) at the end of each month after any deliveries arrive and average monthly distribution is made. New patient and regimen scale up are included in the AMCs used. Only deliveries with a delivery date are included. NMS: Includes deliveries and expected consumption over 6 month period July 1 AMC Adult Adult 300/150/ , /150/ , AZT/3TC 300/150 88, AZT/3TC 300/150 48, TDF/3TC 300/ , TDF/3TC 300/300 78, TDF/3TC/EFV TDF/3TC/EFV 300/300/600 72, /300/600 33, EFV , EFV , NVP , NVP , ATV/r 300/100 3, ATV/r 300/100 2, LPV/r 200/50 16, LPV/r 200/50 6, Paediatric Paediatric 60/30/50 39, /30/50 27, AZT/3TC 60/30 11, AZT/3TC 60/30 7, ABC/3TC 60/30 5, ABC/3TC 60/30 2, EFV 200 4, EFV 200 2, NVP 50 2, NVP 50 1, NVP 100 ml 20, NVP 100 ml 18, LPV/r 100/25 2, LPV/r 100/25 1, LPV/r 80/20 /ml LPV/r 80/20 /ml JMS: Includes deliveries and expected consumption over 6 month period MAUL: Includes deliveries and expected consumption over 6 month period July 1 AMC Adult Adult 300/150/200 16, /150/200 56, AZT/3TC 300/150 7, AZT/3TC 300/150 31, TDF/3TC 300/300 8, TDF/3TC 300/300 27, EFV , EFV , NVP 200 2, NVP , ATV/r 300/ ATV/r 300/ LPV/r 200/50 3, LPV/r 200/50 7, Paediatric Paediatric 60/30/50 1, /30/50 10, AZT/3TC 60/ AZT/3TC 60/30 4, ABC/3TC 60/ ABC/3TC 60/30 2, EFV EFV 200 1, NVP NVP NVP 100 ml NVP 100 ml 1, LPV/r 100/ LPV/r 100/25 1, LPV/r 80/20 /ml LPV/r 80/20 /ml l TDFbased formulations are well stocked nationally; TDF/3TC/EFV will be opened up for ART use, in addition to PMTCT, starting in July NMS is low on adult AZT based formulations and EFV 600. Orders have been placed to fill the public sector ARV gap up to December 2013 and deliveries are expected to arrive in the country between August and October Deliveries from Quality Chemicals Industry Limited (QCIL) are also expected at the end of July 2013 and SCMS shipments expected to arrive at JMS in August 2013 been redirected to NMS. UNITAID will place orders in July for the paediatric drugs that are low in stock at NMS. An order for NVP syrup for emtct has been placed to replenish stock at NMS. In the interim, some stock of NVP syrup will be transfered from JMS to NMS. At MAUL, EFV 100 is available to be used in place of EFV 200 which is stocked out but with pipeline expected by the end of July Further procurement will be initiated to fill any gaps between September to December Increased uptake of the NVP 50 tablets versus the syrup for ART is recommended and interwarehouse transfer of the NVP 50 tablets shall be initiated to avoid expiries. Medicines for Opportunistic Infection Fluconazole 200 6, Fluconazole 2/ml I.V. Infusion 100ml Fluconazole 50/5ml oral suspension Cotrimoxazole 960 Tab** 27, JMS: Includes deliveries and expected consumption over 6 month period Fluconazole Fluconazole 2/ml I.V. Infusion 100ml Fluconazole 50/5ml oral suspension Cotrimoxazole 960 Tab** NMS: Includes deliveries and expected consumption over 6 month period July 1 AMC Fluconazole 200 4, Fluconazole 2/ml I.V. Infusion 100ml Fluconazole 50/5ml oral suspension Cotrimoxazole 960 Tab** 20, MAUL: Includes deliveries and expected consumption over 6 month period July 1 AMC Fluconazole 200 1, Fluconazole 2/ml I.V. Infusion 100ml Fluconazole 50/5ml oral suspension Cotrimoxazole 960 Tab** 6, MAUL has adequate stock of fluconazole tablets. Pfizer has approved a procurement request from Uganda to meet the needs for all the warehouses for 12 months, with delivery dates to be confirmed and expedited. Cotrimoxazole 960 tablets is low on stock at NMS and MAUL, but deliveries are expected in July 2013 for NMS and August 2013 for MAUL. JMS has adequate stock.

11 3. Antimalarials ACT 20/120 tab, 24 pack 54, ACT 20/120 tab, 18 pack 12, ACT 20/120 tab, 12 pack 15, ACT 20/120 tab, 6 pack 27, Artesunate Injection 60/ml 66, Quinine HCl injection, 600/2ml 2, Sulphadoxine Pyrimethamine 1, /25 tab* NMS: Includes deliveries and expected consumption over 6 month period July 1 AMC ACT 20/120 tab, 24 pack 51, ACT 20/120 tab, 18 pack 10, ACT 20/120 tab, 12 pack 14, ACT 20/120 tab, 6 pack 25, Artesunate Injection 60/ml 66, Quinine HCl injection, 600/2ml 2, Sulphadoxine Pyrimethamine 1, /25 tab* JMS: Includes deliveries and expected consumption over 6 month period ACT 20/120 tab, 24 pack 3, ACT 20/120 tab, 18 pack 1, ACT 20/120 tab, 12 pack 1, ACT 20/120 tab, 6 pack 1, Central level stock for ACTs at NMS appear low, however preliminary Medicines Management Supervision reports indicate ~70% facilities are adequately stocked (2+ months). Additional orders have been placed through GF for central level and products are expected by OctDec Deliveries from Quality Chemicals are also expected in July and October NMS continues to call off quinine injection, artesunate injection and SP from the framework contract. JMS is well stocked with ACTs. 4. Laboratory Malaria Rapid diagnostic kits 50, Determine HIV 1/2 Rapid Test Kit 9, PartecCD4 Easy Count Kit 2, Alere Pima CD4 100X Catridge Kit FACS Count CD4/CD3/CD8 50 TESTS 10, NMS: Includes deliveries and expected consumption over 6 month period July 1 AMC Malaria Rapid diagnostic kits 45, Determine HIV 1/2 Rapid Test Kit 7, PartecCD4 Easy Count Kit 1, Alere Pima CD4 100X Catridge Kit FACS Count CD4/CD3/CD8 50 TESTS 7, HUMACOUNT DILUENT HUMACOUNT DILUENT NIHON KOHDEN MEK NIHON KOHDEN MEK DILUENT DILUENT Coulter Diluent Coulter Diluent Sysmex Cell Pack Sysmex Cell Pack HUMAN GOT (ASAT) HUMAN GOT (ASAT) LIQUICOLOR LIQUICOLOR COBAS c 311 ALT COBAS c 311 ALT JMS: Includes deliveries and expected consumption over 6 month period Malaria Rapid diagnostic kits 4, Determine HIV 1/2 Rapid Test Kit 1, PartecCD4 Easy Count Kit Alere Pima CD4 100X Catridge Kit MAUL: Includes deliveries and expected consumption over 6 month period July 1 AMC Determine HIV 1/2 Rapid Test Kit PartecCD4 Easy Count Kit Alere Pima CD4 100X Catridge Kit FACS Count CD4/CD3/CD8 50 TESTS FACS Count CD4/CD3/CD8 50 TESTS 2, HUMACOUNT DILUENT NIHON KOHDEN MEK DILUENT Coulter Diluent Sysmex Cell Pack HUMAN GOT (ASAT) LIQUICOLOR COBAS c 311 ALT There are currently low stock levels at NMS for key laboratory commodities. Procurement for Determine test kits from PEPFAR and Global Fund underway. PEPFAR procurement of CD4 commodities for the public sector underway. Further DFID funding towards lab commodities has been confirmed and allocated towards HIV test kits, Hematology, clinical Chemistry and General reagents. For JMS, deliveries from PEPFAR are to arrive in AugSept 2013 to provide for remainder of year. 0 Anti TB Medicines TB Commodity RHZE tablet 75/150/275/400/ 52, EH twoweek blister strip 400/150 66, RH (Pediatric) tablet 6, RHE (150/75/275 ) 17, RHZ (Pediatric) tablet 60/30/75 4, Streptomycin vial 1g 23, Although central level stock of RH and RHE is low, most health facilities are well stocked. Consignments of RH paed and RHE that arrived recently from GF are to be verified. Global Fund pipeline approved and procurement underway. Capreomycin,Cycloserine, and Paser at risk of expiry. Quantities at risk of expiry will be loaned other countries.

12 Reproductive Health NMS: Includes deliveries and expected consumption over 6 month period Private: Includes deliveries and expected consumption over 6 month period July 1 AMC DepoProvera DepoProvera (Medroxyprogesterone (Medroxyprogesterone Acetate 150/ml INJ) Acetate 150/ml INJ) 236, , Implants (Implanon& Implants (Implanon& Jadelle) Jadelle) 5, , IUD Copper IUD Copper Containing Device Containing Device 1, , TCU380A TCU380A Combined Oral Combined Oral Contraceptives Contraceptives 35, , (Microgynon) (Microgynon) Progestinonly oral Progestinonly oral contraceptives contraceptives (Microlut)[Norgestrel (Microlut)[Norgestrel 3, , ] 0.075] Male Condom (52MM Male Condom (52MM with and without Logo) with and without Logo) 5,000, ,734, Mama Kit 25, Female Condom 685, Female Condom Levonorgestrel , mcg Tab (Emergency Contraceptive) Levonorgestrel 750 Misoprostol 200mcg mcg Tab (Emergency Tabs 2, Contraceptive) Misoprostol 200mcg Tabs 33, Key commodities are well stocked. for products that are stocked out to be monitored. Vaccines No expiry risks to date. Tracer Medicines Measles Vaccine 10 dose vial 18, Bacillus Calmette Guerin (BCG),20 dose 22, vial Human papilloma Virus (HPV),1 dose vial 20, Tetanus toxoid vaccine (TT) 20 dose vial 28, Polio oral trivalent (TopV) 20 dose, vial 33, Polio Oral Bivalent (BOPV) 20 dose vial Although the polio trivalent stock is inadequate, the bivalent vaccine is sufficently stocked to cover the current need no risk of stock outs. DepoProvera (Medroxyprogestero ne Acetate 150/ml INJ) 312, Artemether Lumefantrine 20/120 tab (Green), 24 pack 54, Cotrimoxazole , Oral Rehydration Salts for 1 Litre 13, Measles Vaccine 18, Procurement of ORS to be expedited.